Skip to content 
Is HMPV New Spreading Virus After COVID-19 ?
A flu-like illness is spreading in China, mainly affecting children, causing global concerns about its potential spread.
Cases of human metapneumovirus (HMPV) have also been reported in India, raising attention as respiratory illnesses rise during the winter season.
Here’s everything you need to know about HMPV, how it spreads, and who is at risk.
Human metapneumovirus (HMPV) is a respiratory virus that primarily causes mild upper respiratory infections, often resembling symptoms of the common cold or flu.
First identified in the Netherlands in 2001, HMPV belongs to the family Pneumoviridae, including respiratory syncytial virus (RSV) and parainfluenza virus
Where Are Cases Rising?
China
- Cases are increasing among children under 14, coinciding with the cold winter months.
- China is monitoring pneumonia of unknown origins to track infections.
India
- Seven confirmed cases have been reported in states like Karnataka, Gujarat, Maharashtra, and Tamil Nadu.
- Authorities are boosting surveillance and urging people to follow basic precautions like handwashing.
United Kingdom
In late December 2024, 4.5% of lab samples tested positive for HMPV. This is lower than flu (29.5%) but higher than COVID-19 (2.5%).
What are the most common symptoms of HMPV?
The most common symptoms of Human Metapneumovirus (HMPV) resemble those of other respiratory infections, such as the flu or common cold. These symptoms can vary in severity depending on the age and health status of the individual. Here are the typical symptoms associated with HMPV:
- Cough: Often persistent, sometimes accompanied by mucus production.
- Fever: Generally low-grade in healthy adults but can be higher in vulnerable populations.
- Nasal Congestion: This includes a runny nose or stuffiness.
- Sore Throat: A common complaint among those infected.
- Shortness of Breath: More pronounced in severe cases, particularly among individuals with pre-existing conditions.
In children, symptoms may also include:
- Wheezing: Particularly in younger children and infants.
- Difficulty Breathing: This can be more severe in young children.
- Vomiting: Sometimes observed in younger populations.
While most cases are mild and typically resolve within one to two weeks, severe cases can lead to complications such as bronchiolitis or pneumonia, especially in infants, older adults, and individuals with compromised immune systems
